Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: GSK(GSK) the Revenue is 11.15 B (+1.87%), Beat estimate;the EBIT is 3.713 B (+2.96%), Beat estimate;the EPS is 0.285 (-69.59%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
11.15B1.87%
10.94B0.10%
+0.22B1.97%
EBITExceed expectations
3.71B2.96%
3.51B2.67%
+0.20B5.63%
EPSMiss expectations
0.284869.59%
1.01258.13%
-0.727777.72%
Upcoming earnings report - Q3 FY2026
Available dateOct 28, 2026
Estimate Revenue$12 B
Estimate EBIT--
Estimate EPS$1.1201
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf